HCPCS Level II
J2426
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
Codes near J2426
These sit next to J2426 in the CMS Level II file. All J codes
- J2405Injection, ondansetron hydrochloride, per 1 mg
- J2406Injection, oritavancin (kimyrsa), 10 mg
- J2407Injection, oritavancin (orbactiv), 10 mg
- J2410Injection, oxymorphone hcl, up to 1 mg
- J2425Injection, palifermin, 50 micrograms
- J2427Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
- J2428Injection, paliperidone palmitate extended release (erzofri), 1 mg
- J2430Injection, pamidronate disodium, per 30 mg
- J2440Injection, papaverine hcl, up to 60 mg
- J2460Injection, oxytetracycline hcl, up to 50 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50458-0560-01 | Invega Sustenna | Janssen Pharmaceuticals, Inc. | 39 |
| 50458-0561-01 | Invega Sustenna | Janssen Pharmaceuticals, Inc. | 78 |
| 50458-0562-01 | Invega Sustenna | Janssen Pharmaceuticals, Inc. | 117 |
| 50458-0563-01 | Invega Sustenna | Janssen Pharmaceuticals, Inc. | 156 |
| 50458-0564-01 | Invega Sustenna | Janssen Pharmaceuticals, Inc. | 234 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.